| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |